638 related articles for article (PubMed ID: 12828159)
41. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia.
Shahmahmoodi S; Parvaneh N; Burns C; Asghar H; Mamishi S; Tabatabaie H; Chen Q; Teimourian S; Gooya MM; Esteghamati AR; Mousavi T; Yousefi M; Farrokhi K; Mashlool M; Kew O; Nategh R
Virus Res; 2008 Oct; 137(1):168-72. PubMed ID: 18674576
[TBL] [Abstract][Full Text] [Related]
42. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
[TBL] [Abstract][Full Text] [Related]
43. Vaccine-associated paralytic polio in India.
John TJ
Bull World Health Organ; 2002; 80(11):917. PubMed ID: 12481217
[No Abstract] [Full Text] [Related]
44. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002-June 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(38):913-6. PubMed ID: 14508441
[TBL] [Abstract][Full Text] [Related]
45. Commentary on the oral poliomyelitis vaccine (Sabin) -- associated cases of acute persisting spinal paralysis.
Biberi-Moroeanu S; Muntiu A
Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):355-68. PubMed ID: 757664
[No Abstract] [Full Text] [Related]
46. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
47. Vaccine-associated paralytic poliomyelitis: a case report of domiciliary transmission.
Paz JA; Vallada MG; Marques SN; Casella EB; Marques HH; Marques-Dias MJ
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(3):101-4. PubMed ID: 10983013
[TBL] [Abstract][Full Text] [Related]
48. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
Sosa-Díaz RY; Más-Lago P; Valdés-Ramírez O; Sarmiento-Pérez L
Rev Neurol; 2003 May 1-15; 36(9):812-6. PubMed ID: 12717666
[TBL] [Abstract][Full Text] [Related]
49. Field evaluation of trivalent oral polio vaccine efficacy in Madras city--a case control study.
Ramasamy DJ
J Commun Dis; 1994 Sep; 26(3):151-5. PubMed ID: 7868838
[TBL] [Abstract][Full Text] [Related]
50. Vaccine-associated poliomyelitis in a child with thymic abnormality.
Riker JB; Brandt CD; Chandra R; Arrobio JO; Nakano JH
Pediatrics; 1971 Dec; 48(6):923-9. PubMed ID: 4331606
[No Abstract] [Full Text] [Related]
51. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
[TBL] [Abstract][Full Text] [Related]
52. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.
Aylward RB; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):40-6. PubMed ID: 15106299
[TBL] [Abstract][Full Text] [Related]
53. A case of paralytic poliomyelitis associated with poliovirus vaccine strains in Hokkaido, Japan.
Miyoshi M; Yoshizumi S; Jinushi M; Ishida S; Okui T; Okano M; Shouji M; Tanaka S; Saigusa J; Mori A; Tanabe H; Yamaguchi R; Nishimura Y; Shimizu H
Jpn J Infect Dis; 2010 May; 63(3):216-7. PubMed ID: 20495280
[No Abstract] [Full Text] [Related]
54. [Recent advance in research on the incidence of paralysis following immunization with live oral polio vaccine].
Hu XM
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Apr; 6(2):125-7. PubMed ID: 2990717
[No Abstract] [Full Text] [Related]
55. Paralytic polio in an adult female following OPV vaccination of her infant.
Blain JG; Osterman JW; Baghdadllan H; Lambert L
Can Commun Dis Rep; 1993 Aug; 19(15):118-9. PubMed ID: 8220290
[No Abstract] [Full Text] [Related]
56. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.
Shaghaghi M; Shahmahmoodi S; Abolhassani H; Soleyman-Jahi S; Parvaneh L; Mahmoudi S; Chavoshzadeh Z; Yazdani R; Zahraei SM; Ebrahimi M; Eslamian MH; Tabatabaie H; Yousefi M; Kandelousi YM; Oujaghlou A; Rezaei N; Aghamohammadi A
Emerg Infect Dis; 2016 Oct; 22(10):1712-9. PubMed ID: 27648512
[TBL] [Abstract][Full Text] [Related]
57. Problems of live virus vaccine-associated poliomyelitis a paralytic case with isolation of all three poliovirus types.
Mertens T; Schürmann W; Kruppenbacher J; Rheingans K; Kellermann K; Maass G; Eggers HJ
Med Microbiol Immunol; 1983; 172(1):13-21. PubMed ID: 6308406
[TBL] [Abstract][Full Text] [Related]
58. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
59. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
Strebel PM; Aubert-Combiescu A; Ion-Nedelcu N; Biberi-Moroeanu S; Combiescu M; Sutter RW; Kew OM; Pallansch MA; Patriarca PA; Cochi SL
Am J Epidemiol; 1994 Dec; 140(12):1111-24. PubMed ID: 7998593
[TBL] [Abstract][Full Text] [Related]
60. Absence of wild poliovirus circulation among healthy children in a rural area with high oral poliovirus vaccination coverage.
Deshpande JM; Rao VK; Karnataki MV; Nadkarni SS; Saxena VK; Karambelkar RR; Ramdasi SG; Patil KS; Rodrigues JJ
Indian J Med Res; 1996 Jun; 103():289-93. PubMed ID: 8707367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
